Silver Book Fact

High-intensity ultrasonic cyclocoagulation reduces intraocular pressure in refractory glaucoma patients.

Aptel F, Charrell T, Lafon C, Ramano F, et al. Miniaturized High-Intensity Focused Ultrasound Device in Patients with Glaucoma: A clinical pilot study. Invest Opthalmol Vis Sci. 2011; 52(12): 8747-8753. http://iovs.arvojournals.org/article.aspx?articleid=2187000

Reference

Title
Miniaturized High-Intensity Focused Ultrasound Device in Patients with Glaucoma: A clinical pilot study
Publication
Invest Opthalmol Vis Sci
Publication Date
2011
Authors
Aptel F, Charrell T, Lafon C, Ramano F, et al
Volume & Issue
Volume 52, Issue 12
Pages
8747-8753
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Lucentis to treat wet age-related macular degeneration (AMD)
    An FDA-approved ophthalmic drug that treats wet age-related macular degeneration (AMD)–ranibizumab (Lucentis)–maintained vision in 95% of clinical trial participants and improved vision by 15 or more letters in approximately 25%…  
  • AMD risk reduction through diet
    A recent study indicated that 20% of AMD cases in the AREDS study would have been eliminated if the participants consumed diets with a dGI (dietary glycemic index) below the…  
  • Timely treatment and follow-up care can reduce the risk of blindness in individuals with proliferative retinopathy by 95%.  
  • Screening and treatment for diabetic retinopathy in type 2 diabetes patients produces annual savings of 53,986 person-years of sight.  
  • Detection and treatment of proliferative diabetic eye disease and clincally significant macular edema with laser therapy can reduce severe vision loss progression by 50% to 60%